Microfluidics-Based Systems in Diagnosis of Alzheimer’s Disease and Biomimetic Modeling

Microfluidics-Based Systems in Diagnosis of Alzheimer’s Disease and Biomimetic Modeling

Early detection and accurate diagnosis of Alzheimer’s disease (AD) is essential for patient care and disease treatment. Microfluidic technology is emerging as an economical and versatile platform in disease detection and diagnosis. It can be conveniently integrated with nanotechnology and/or biologi...

Full description

Bibliographic Details
Main Authors:	Yan Li, Danni Li, Pei Zhao, Krishnaswamy Nandakumar, Liqiu Wang, Youqiang Song
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Micromachines
Subjects:	Alzheimer’s disease (AD) microfluidic chips AD biomarkers blood–brain barrier (BBB) three-dimensional AD model
Online Access:	https://www.mdpi.com/2072-666X/11/9/787

Similar Items

Alzheimer´s disease: a clinical-practice-oriented review
by: Luísa eAlves, et al.
Published: (2012-04-01)

Fish-on-a-chip: a sensitive detection microfluidic system for alzheimer's disease
by: An Jeongho, et al.
Published: (2011-05-01)

Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics
by: Chaahat S.B. Singh, et al.
Published: (2021-09-01)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
by: Yuhai Zhao, et al.
Published: (2020-10-01)

The role of melatonin in the onset and progression of type 3 diabetes
by: Juhyun Song, et al.
Published: (2017-08-01)

Implications of Glycosylation in Alzheimer’s Disease
by: Henriette Haukedal, et al.
Published: (2021-01-01)

A microfluidic model of human brain (μHuB) for assessment of blood brain barrier
by: Tyler D. Brown, et al.
Published: (2019-05-01)

A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
by: Nienke R. Wevers, et al.
Published: (2018-08-01)

Nanomedicine Against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
by: Francesca Pederzoli, et al.
Published: (2019-11-01)

Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies
by: Liu Shi, et al.
Published: (2021-07-01)

Update on Alzheimer’s Disease
by: Kurt A. Jellinger
Published: (2015-08-01)

Bioengineered microfluidic blood-brain barrier models in oncology research
by: Robin Augustine, et al.
Published: (2021-07-01)

Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies
by: Maria Inês Teixeira, et al.
Published: (2020-06-01)

When Does Alzheimer′s Disease Really Start? The Role of Biomarkers
by: Ana Lloret, et al.
Published: (2019-11-01)

Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease
by: Haitao Yu, et al.
Published: (2018-03-01)

Potential applications of microfluidics based blood brain barrier (BBB)-on-chips for in vitro drug development
by: Xiaobo Wang, et al.
Published: (2020-12-01)

Alzheimer’s disease hypothesis and related therapies
by: Xiaoguang Du, et al.
Published: (2018-01-01)

Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer’s Disease
by: Pingfang Qi, et al.
Published: (2020-10-01)

Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9
by: Anushruti Ashok, et al.
Published: (2016-11-01)

In Vitro Blood–Brain Barrier-Integrated Neurological Disorder Models Using a Microfluidic Device
by: Jin-Ha Choi, et al.
Published: (2019-12-01)

INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia
by: Andy P. Tsai, et al.
Published: (2021-06-01)

Management of Alzheimer's disease
by: Michael Rainer, et al.
Published: (2019-01-01)

Dyrk1 inhibition improves Alzheimer's disease-like pathology
by: Branca, Caterina, et al.
Published: (2017)

Current animal models of Alzheimer´s disease: challenges in translational research
by: Mar eCuadrado-Tejedor, et al.
Published: (2014-09-01)

SOME PSYCHOPATHOLODICAL PECULIARITIES AT EARLY AND LATE ONSET IN PATIENTS WITH ALZHEIMER'S DISEASE
by: Mariana Arnaoudova
Published: (2010-11-01)

Resting-state electroencephalographic biomarkers of Alzheimer’s disease
by: Giordano Cecchetti, et al.
Published: (2021-01-01)

Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
by: Friedrich Leblhuber, et al.
Published: (2019-07-01)

Nonvascular retinal imaging markers of preclinical Alzheimer's disease
by: Peter J. Snyder, et al.
Published: (2016-01-01)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
by: Walter J. Lukiw, et al.
Published: (2020-09-01)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
by: Annie M. Racine, et al.
Published: (2018-01-01)

Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model
by: R. Scherzer-Attali, et al.
Published: (2012-06-01)

Upregulation of RIN3 induces endosomal dysfunction in Alzheimer’s disease
by: Ruinan Shen, et al.
Published: (2020-06-01)

Systemic and central nervous system metabolic alterations in Alzheimer’s disease
by: Vera van der Velpen, et al.
Published: (2019-11-01)

Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How
by: Cutler T. Lewandowski, et al.
Published: (2020-06-01)

Systems biology and bioinformatics approach to identify gene signatures, pathways and therapeutic targets of Alzheimer's disease
by: Utpala Nanda Chowdhury, et al.
Published: (2020-01-01)

Alzheimer's disease - the role of nurses in patient care
by: Patrycja Polańska, et al.
Published: (2019-06-01)

Design and Validation of a Human Brain Endothelial Microvessel-on-a-Chip Open Microfluidic Model Enabling Advanced Optical Imaging
by: Mootaz M. Salman, et al.
Published: (2020-09-01)

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
by: Susanne Ostrowitzki, et al.
Published: (2017-12-01)

Inter-band Bispectral Analysis of EEG Background Activity to Characterize Alzheimer's Disease Continuum
by: Aarón Maturana-Candelas, et al.
Published: (2020-09-01)

A Complete Protocol for Rapid and Low-Cost Fabrication of Polymer Microfluidic Chips Containing Three-Dimensional Microstructures Used in Point-of-Care Devices
by: Trieu Nguyen, et al.
Published: (2019-09-01)

Cannot write session to /tmp/vufind_sessions/sess_pu8udhud11llvg08hihtf01k7f